EQS-Adhoc: LifeWatch AG: AEVIS VICTORIA SA accepts BioTelemetry's revised offer
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer
LifeWatch AG: AEVIS VICTORIA SA accepts BioTelemetry's revised offer
24-May-2017 / 11:26 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
--------------------------------------------------------------------------------
AEVIS VICTORIA SA accepts BioTelemetry's revised offer
Zug/Switzerland, May 24, 2017 - AEVIS VICTORIA SA (SWX: AEVS) announced today
that it will tender its shares into BioTelemetry's revised takeover offer for
LifeWatch Ltd.
Further details are available on the AEVIS VICTORIA SA website (seehttp://www.ae
vis.com/websites/aevis/English/2111/ad-hoc-press-releases.html?newsID=1625815).
For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Communicators AG , Ralph Spillmann
Mobile: +41 79 514 64 84
E-Mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland, Israel and Turkey, and is the parent company of LifeWatch
Services Inc., LifeWatch Technologies, Ltd. and LifeWatch Turkey Holding AG
(joint venture). LifeWatch Services, Inc. is a leading U.S.-based provider of
cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a
leading manufacturer of digital health products. LifeWatch Sağlık Hizmetlerine
A.S. is the operative Turkish subsidiary of LifeWatch Turkey Holding AG and
provider of mobile cardiac telemetry services in Turkey. For additional
information, please visitwww.lifewatch.com.
Sign up for customized e-mail alerts and documentation requests at
https://www.lifewatch.com/Investor-Relations/Alert-Service.html
This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST
NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL
CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE
UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF
LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED
WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS.
Additional features:
Document:http://n.eqs.com/c/fncls.ssp?u=ETJIWWNRPY
Document title: 20170524_Aevis acceptance_EN
--------------------------------------------------------------------------------
End of ad hoc announcement------------------------------------------------------
Language: English
Company: LifeWatch AG
Baarerstrasse 139
6300 Zug
Switzerland
Phone: +41 41 728 67 78
Internet: www.lifewatch.com
ISIN: CH0012815459
Valor: 811189
Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt; SIX Swiss Exchange
End of Announcement EQS Group News Service
--------------------------------------------------------------------------------
577035 24-May-2017 CET/CEST
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: BioTelemetry announces increase of price in its public offer for LifeWatch 24-May-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576859 24-May-2017 CET/CEST ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: BioTelemetry, Inc. announces extension of the main offer period for public offer for LifeWatch AG 22-May-2017 / 23:11 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576305 22-May-2017 CET/CEST ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: Main offer period of BioTelemetry, Inc.'s tender offer for LifeWatch AG shares begins 10-May-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 571635 10-May-2017 CET/CEST ...